TY  - JOUR 
AU  - Salazar-Ospina, Andrea
AU  - Amariles Muñoz, Pedro
AU  - Benjumea, Dora M.
AU  - Gutiérrez, Francisco
AU  - Faus Dader, María José
AU  - Rodríguez, Luis F.
PY  - 2014
SN  - 1745-6215
UR  - http://hdl.handle.net/10481/32372
AB  - Background

Bipolar I disorder (BD-I) is a chronic mental illness characterized by the presence of one or more manic episodes, or both depressive and manic episodes, usually separated by asymptomatic intervals. Pharmacists can contribute to the...
AB  - Methods/design

Randomized, controlled, prospective, single-center clinical trial with duration of 12 months will be performed to compare the effect of Dader Method of pharmaceutical care with the usual care process of patients in a psychiatric...
AB  - Discussion

As far as we know, this is the first randomized controlled trial to assess the effect of the Dader Method for pharmaceutical care in patients with BD-I and it could generate valuable information and recommendations about the role of...
AB  - Trial registration

Registration number NCT01750255 on August 6, 2012. First patient randomized on 24 November 2011.
LA  - eng
PB  - Biomed Central
KW  - Bipolar disorders
KW  - Drug-related problems
KW  - Pharmacutical care
KW  - Pharmacotherapy follow-up
KW  - Community pharmacy services
KW  - Pharmacists
KW  - Outpatients
TI  - Effectiveness of the Dader Method for pharmaceutical care in patients with bipolar I disorder: EMDADER-TAB: study protocol for a randomized controlled trial
DO  - 10.1186/1745-6215-15-174
ER  -